aTYR PHARMA CEO Sanjay Shukla's 2021 pay jumps 75% to $1.9M
aTYR PHARMA reports 2021 executive compensation
By ExecPay News
Published: March 22, 2022
aTYR PHARMA reported fiscal year 2021 executive compensation information on March 22, 2022.
In 2021, three executives at aTYR PHARMA received on average a compensation package of $1.2M, a 54% increase compared to previous year.
Average pay of disclosed executives at aTYR PHARMA
Sanjay S. Shukla, Chief Executive Officer, received $1.9M in total, which increased by 75% compared to 2020. 57% of Shukla's compensation, or $1.1M, was in option awards. Shukla also received $293K in non-equity incentive plan, $510K in salary, as well as $13K in other compensation.
Jill M. Broadfoot, Chief Financial Officer, received a compensation package of $917K, which increased by 31% compared to previous year. 41% of the compensation package, or $377K, was in salary.
Nancy E. Denyes, General Counsel, earned $891K in 2021, a 43% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on March 22, 2022.